PUBLIC CONTRACT · 2023
Aquisição de Certolizumab pegol 200 mg pelo Hospital de Santo Espírito da Ilha Terceira, E.P.E.R.
- Contract value
- €25,068.96
- Signed on
- 10 January 2023
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9725685PUBLISHED SUBJECT
Aquisição de Certolizumab pegol 200 mg pelo Hospital de Santo Espírito da Ilha Terceira, E.P.E.R.
Parties involved
- Place of performance
- Portugal, Região Autónoma dos Açores, Angra do Heroismo
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- UCB PHARMA (PRODUTOS FARMACÊUTICOS), LIMITADA · Tax ID 500291322
Values and timeline
- Contract price
- €25,068.96
- Procedure base price
- €25,068.96
- Total effective price
- €24,748.56
- Publication date
- 23 January 2023
- Award date
- 7 December 2022
- Signing date
- 10 January 2023
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Multifator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017) e Lei n.º 30/2021, de 21.05 e DLR no 27/2015/A, de 29.12
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6166151
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.